China accounts for 90% of global vitamin C output, 70% of citric acid output and 90% of penicillin output
Los Angeles, CA (PRWEB) December 18, 2011
In the five years through 2016, the international medical market will expand by between 10% and 13%, and the Pharmaceutical Raw Material Manufacturing industry will therefore increase steadily. According to IBISWorld, China has become the world's third largest medicine market. With billions of dollars’ worth of pharmaceutical patents set to expire in the next few years, industry revenue is forecast to grow at an average annual rate of 11.9% to $80.87 billion in 2016.
China is the largest producer of pharmaceutical raw materials in the world, accounting for roughly 90% of global vitamin C output, 70% of citric acid output and 90% of penicillin output.
Rising health concerns of the Chinese people and strong global demand led to rapid industry growth in the past five years. However, as the global economic downturn began to affect industry exports from the fourth quarter of 2008, exports stagnated in 2009.
Total revenue for the Pharmaceutical Raw Material Manufacturing industry in China is expected to be $46.17 billion in 2011, up 20.1% from 2010.
This industry heavily relies on exports, with almost half of the industry's revenue coming from foreign markets. Although exports stagnated in 2009 with an increase of only 0.2% due to lower foreign demand from the global economic downturn, exports still accounted for 52.4% of industry revenue. In 2011, exports are forecast to increase by 8.4% to $19.84 billion.
For more information, including profit levels, market shares, product segmentation and more, download IBISWorld’s report on the Pharmaceutical Raw Material Manufacturing industry in China.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189
The Pharmaceutical Raw Materials Manufacturing industry in China comprises firms that manufacture active pharmaceutical ingredients for further preparation of finished pharmaceutical products. Typical products in the industry include bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. This industry acts as a bridge between the upstream chemical industry and the downstream medical market.
The Pharmaceutical Raw Material Manufacturing in China Report Key Topics
Key External Drivers
Industry Life Cycle
Products & Markets
Products & Services
Globalization & Trade
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on 200 Chinese industries. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com.cn or call 1-800-330-3772.
# # #